Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | FURIN | P09958 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2197175 | 0.98 | FURIN (0.38) | OPRM1OPRD1OPRK1FURIN | |
| SCHEMBL2194131 | 0.90 | OPRM1 (0.41) | OPRM1OPRD1OPRK1FURIN | |
| SCHEMBL4082464 | 0.77 | OPRM1 (0.39) | OPRM1OPRD1OPRK1 | |
| SCHEMBL9813485 | 0.75 | MMP2 (0.38) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29645145 | 0.75 | BACE1 (0.46) | — | |
| SCHEMBL4086999 | 0.73 | TERT (0.38) | — | |
| SCHEMBL29822509 | 0.72 | OPRM1 (0.51) | OPRM1OPRD1OPRK1 | |
| SCHEMBL6240790 | 0.71 | PTGS1 (0.39) | — | |
| SCHEMBL29576722 | 0.71 | OPRM1 (0.48) | OPRM1OPRD1OPRK1 | |
| SCHEMBL4082330 | 0.71 | DPP4 (0.35) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NEKTAR THERAPEUTICS (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166063-A1 | POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES | NGLY1, CD44, IAPP | OPRM1 2317/4885OPRD1 3100/4885OPRK1 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.